FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2890696535> ?p ?o ?g. }

• W2890696535 endingPage "78" @default.
• W2890696535 startingPage "70" @default.
• W2890696535 abstract "Abstract Background Rheumatoid arthritis (RA) is an inflammatory autoimmune disease which leads to bone and cartilage erosion. Oxidative stress and pro-inflammatory cytokines plays crucial role in the pathophysiology of RA. Cinnamaldehyde and eugenol have a long history of medical use in various inflammatory disorders. Purpose The drugs available for the treatment of RA are associated with various side effects. The present study was conducted to evaluate the anti-arthritic effects of cinnamaldehyde and eugenol in rat model of arthritis. Methods Type II collagen was intradermally injected to rats for the induction of arthritis. Cinnamaldehyde (10 and 20 mg/kg/day) and eugenol (10 and 20 mg/kg/day) were given orally for 15 days, starting from day 21 to 35. Dexamethasone treated rats served as positive control. Histological, radiological and scanning electron microscopic analysis were done to monitor the effect of compounds on collagen induced arthritis (CIA). Reactive oxygen species (ROS) formation, nitric oxide and antioxidant status were also determined. The markers of biomolecular oxidation (protein, lipid and DNA) and activities of enzymatic antioxidants (superoxide dismutase, glutathione peroxidase, catalase and glutathione reductase) were also evaluated in the joint homogenate and plasma of rats. For detecting inflammation, levels of TNF-α, IL-6 and IL-10 were monitored by ELISA. Results Our results showed anti-oxidant and anti-inflammatory effects of cinnamaldehyde and eugenol in arthritic rats. Scanning electron microscopy, histopathological and radiological findings also confirmed the anti-arthritic effects of cinnamaldehyde and eugenol. Both the compounds were effective in bringing significant decrease in the levels of ROS, nitric oxide, markers of biomolecular oxidation and increase in enzymatic and non-enzymatic antioxidants. The levels of TNF-α, IL-6 and IL-10 were also ameliorated by cinnamaldehyde and eugenol treatment. Between the two phytochemicals used, eugenol was found to be more effective than cinnamaldehyde in reducing the severity of arthritis. Conclusion Cinnamaldehyde and eugenol were effective in ameliorating oxidative stress and inflammation in arthritic rats. These findings indicate that cinnamaldehdye and eugenol have a great potential to be used as an adjunct in the management of RA." @default.
• W2890696535 created "2018-09-27" @default.
• W2890696535 creator A5018647877 @default.
• W2890696535 creator A5046139094 @default.
• W2890696535 creator A5051692793 @default.
• W2890696535 creator A5056282324 @default.
• W2890696535 creator A5070550106 @default.
• W2890696535 creator A5071044957 @default.
• W2890696535 creator A5072980370 @default.
• W2890696535 creator A5075934970 @default.
• W2890696535 date "2019-02-01" @default.
• W2890696535 modified "2023-10-02" @default.
• W2890696535 title "Cinnamaldehyde and eugenol attenuates collagen induced arthritis via reduction of free radicals and pro-inflammatory cytokines" @default.
• W2890696535 cites W1545899030 @default.
• W2890696535 cites W1546592314 @default.
• W2890696535 cites W1590457525 @default.
• W2890696535 cites W1759061013 @default.
• W2890696535 cites W1775749144 @default.
• W2890696535 cites W191793640 @default.
• W2890696535 cites W1965026439 @default.
• W2890696535 cites W1969775578 @default.
• W2890696535 cites W1973322265 @default.
• W2890696535 cites W1976392585 @default.
• W2890696535 cites W1995671655 @default.
• W2890696535 cites W2017058203 @default.
• W2890696535 cites W2022252206 @default.
• W2890696535 cites W2022446807 @default.
• W2890696535 cites W2035158278 @default.
• W2890696535 cites W2041076416 @default.
• W2890696535 cites W2049094525 @default.
• W2890696535 cites W2052421332 @default.
• W2890696535 cites W2060031759 @default.
• W2890696535 cites W2067068975 @default.
• W2890696535 cites W2071834164 @default.
• W2890696535 cites W2073092594 @default.
• W2890696535 cites W2075590923 @default.
• W2890696535 cites W2077399157 @default.
• W2890696535 cites W2078746146 @default.
• W2890696535 cites W2081371122 @default.
• W2890696535 cites W2082109759 @default.
• W2890696535 cites W2092629964 @default.
• W2890696535 cites W2105261402 @default.
• W2890696535 cites W2106171259 @default.
• W2890696535 cites W2110826367 @default.
• W2890696535 cites W2114713913 @default.
• W2890696535 cites W2146163019 @default.
• W2890696535 cites W2146607274 @default.
• W2890696535 cites W2157481017 @default.
• W2890696535 cites W2159705610 @default.
• W2890696535 cites W2165292984 @default.
• W2890696535 cites W2177023445 @default.
• W2890696535 cites W2263023695 @default.
• W2890696535 cites W2273452210 @default.
• W2890696535 cites W2313462881 @default.
• W2890696535 cites W2336588424 @default.
• W2890696535 cites W2410721293 @default.
• W2890696535 cites W2529013142 @default.
• W2890696535 cites W2533020242 @default.
• W2890696535 cites W2607499691 @default.
• W2890696535 cites W2776794339 @default.
• W2890696535 doi "https://doi.org/10.1016/j.phymed.2018.09.004" @default.
• W2890696535 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30668414" @default.
• W2890696535 hasPublicationYear "2019" @default.
• W2890696535 type Work @default.
• W2890696535 sameAs 2890696535 @default.
• W2890696535 citedByCount "39" @default.
• W2890696535 countsByYear W28906965352019 @default.
• W2890696535 countsByYear W28906965352020 @default.
• W2890696535 countsByYear W28906965352021 @default.
• W2890696535 countsByYear W28906965352022 @default.
• W2890696535 countsByYear W28906965352023 @default.
• W2890696535 crossrefType "journal-article" @default.
• W2890696535 hasAuthorship W2890696535A5018647877 @default.
• W2890696535 hasAuthorship W2890696535A5046139094 @default.
• W2890696535 hasAuthorship W2890696535A5051692793 @default.
• W2890696535 hasAuthorship W2890696535A5056282324 @default.
• W2890696535 hasAuthorship W2890696535A5070550106 @default.
• W2890696535 hasAuthorship W2890696535A5071044957 @default.
• W2890696535 hasAuthorship W2890696535A5072980370 @default.
• W2890696535 hasAuthorship W2890696535A5075934970 @default.
• W2890696535 hasConcept C139066938 @default.
• W2890696535 hasConcept C161790260 @default.
• W2890696535 hasConcept C178790620 @default.
• W2890696535 hasConcept C185592680 @default.
• W2890696535 hasConcept C203014093 @default.
• W2890696535 hasConcept C2776914184 @default.
• W2890696535 hasConcept C2777077863 @default.
• W2890696535 hasConcept C2777435628 @default.
• W2890696535 hasConcept C2778844214 @default.
• W2890696535 hasConcept C2780470866 @default.
• W2890696535 hasConcept C3020196126 @default.
• W2890696535 hasConcept C55493867 @default.
• W2890696535 hasConcept C71924100 @default.
• W2890696535 hasConcept C98274493 @default.
• W2890696535 hasConceptScore W2890696535C139066938 @default.
• W2890696535 hasConceptScore W2890696535C161790260 @default.
• W2890696535 hasConceptScore W2890696535C178790620 @default.
• W2890696535 hasConceptScore W2890696535C185592680 @default.

• next